Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Yara Abdou, MD

The University of North Carolina at Chapel Hill

Presented in Memory of Chawnte’ Randall

Investigating Survivin as a novel target for immunotherapy in Black women with breast cancer

Swarnali Acharyya, PhD

Columbia University Irving Medical Center (CUIMC)

Presented by The Met Gala Santa Clarita in honor of Amy Steffe Lohmann and Eva Miranda Crawford

Targeting S100A9 signaling to treat therapy-resistant brain metastases in HER2+ breast cancer

SWARNALI ACHARYYA, PhD

Institute for Cancer Genetics, Columbia University

Reactivating anti-tumor granulocytic cells to provoke immune attack against breast cancer metastasis

JULIO AGUIRRE-GHISO, PhD

Icahn School of Medicine

Targeting Intrinsic And Immune Mechanisms In Persistent Dormant Cancer Cells In Stage IV Breast Cancer

Prasanna Alluri, MD, PhD

UT Southwestern Medical Center at Dallas

Presented in honor of Erin Remme by Minneapolis Metsquerade

Identifying Therapeutic Vulnerabilities in RB1-negative, ER-positive Breast Cancers

Prasanna Alluri, MD, PhD

The University of Texas Southwestern Medical Center at Dallas

Presented by #LightUpMBC Ambassador team in memory of Jessica Moore

Targeting CDK4/6 inhibitor resistance in patients with metastatic, ER-positive breast cancer

Eran Andrechek, Ph.D.

Michigan State University

Identification of driver mutations that regulate metastasis

Andrei Bakin, PhD

Roswell Park Cancer Center

A Novel Combination Therapy to Improve Treatment of Metastatic Breast Cancer

Andrei Bakin, PhD

Roswell Park Comprehensive Cancer Center

Presented by #LightUpMBC Ambassador team in memory of Rosylin Weston

Development of Novel Immune Therapy Approaches for Metastatic Breast Cancer

Jill Bargonetti, PhD

City University of New York at Hunter College

Presented in honor of Caroline McIntyre and in memory of Sandy Gagliardi, members of Living with MBC Support Group in DENJPA

Targeting Breast Cancer Metastasis by Combination Inhibition of CXCR4 and MDM2/MDM4

Jill Bargonetti, PhD

City University of New York (CUNY) at Hunter College

Presented by NWA Metsquerade in Memory of Lisa Quinn and In Honor of Kelli Davis

Targeting Metastatic Breast Cancer Through the Mutant p53-PARP Axis

Reva Basho, MD

Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute

Presented by Metavivor Facebook Fundraisers

Tucatinib in Combination with Pembrolizumab and Trastuzumab for Patients with HER2+ Breast Cancer Brain Metastases